Cargando…

Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling

Pulmonary arterial hypertension is a disease of proliferative vascular occlusion that is strongly linked to mutations in BMPR2—the gene encoding the BMPR-II (BMP [bone morphogenetic protein] type II receptor). The endothelial-selective BMPR-II ligand, BMP9, reverses disease in animal models of pulmo...

Descripción completa

Detalles Bibliográficos
Autores principales: Theilmann, Anne L., Hawke, Lindsey G., Hilton, L. Rhiannon, Whitford, Mara K.M., Cole, Devon V., Mackeil, Jodi L., Dunham-Snary, Kimberly J., Mewburn, Jeffrey, James, Paula D., Maurice, Donald H., Archer, Stephen L., Ormiston, Mark L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571847/
https://www.ncbi.nlm.nih.gov/pubmed/32998516
http://dx.doi.org/10.1161/ATVBAHA.119.313357
_version_ 1783597231813689344
author Theilmann, Anne L.
Hawke, Lindsey G.
Hilton, L. Rhiannon
Whitford, Mara K.M.
Cole, Devon V.
Mackeil, Jodi L.
Dunham-Snary, Kimberly J.
Mewburn, Jeffrey
James, Paula D.
Maurice, Donald H.
Archer, Stephen L.
Ormiston, Mark L.
author_facet Theilmann, Anne L.
Hawke, Lindsey G.
Hilton, L. Rhiannon
Whitford, Mara K.M.
Cole, Devon V.
Mackeil, Jodi L.
Dunham-Snary, Kimberly J.
Mewburn, Jeffrey
James, Paula D.
Maurice, Donald H.
Archer, Stephen L.
Ormiston, Mark L.
author_sort Theilmann, Anne L.
collection PubMed
description Pulmonary arterial hypertension is a disease of proliferative vascular occlusion that is strongly linked to mutations in BMPR2—the gene encoding the BMPR-II (BMP [bone morphogenetic protein] type II receptor). The endothelial-selective BMPR-II ligand, BMP9, reverses disease in animal models of pulmonary arterial hypertension and suppresses the proliferation of healthy endothelial cells. However, the impact of BMPR2 loss on the antiproliferative actions of BMP9 has yet to be assessed. APPROACH AND RESULTS: BMP9 suppressed proliferation in blood outgrowth endothelial cells from healthy control subjects but increased proliferation in blood outgrowth endothelial cells from pulmonary arterial hypertension patients with BMPR2 mutations. This shift from growth suppression to enhanced proliferation was recapitulated in control human pulmonary artery endothelial cells following siRNA-mediated BMPR2 silencing, as well as in mouse pulmonary endothelial cells isolated from endothelial-conditional Bmpr2 knockout mice (Bmpr2(EC)(−/−)). BMP9-induced proliferation was not attributable to altered metabolic activity or elevated TGFβ (transforming growth factor beta) signaling but was linked to the prolonged induction of the canonical BMP target ID1 in the context of BMPR2 loss. In vivo, daily BMP9 administration to neonatal mice impaired both retinal and lung vascular patterning in control mice (Bmpr2(EC+/+)) but had no measurable effect on mice bearing a heterozygous endothelial Bmpr2 deletion (Bmpr2(EC+/−)) and caused excessive angiogenesis in both vascular beds for Bmpr2(EC)(−/−) mice. CONCLUSIONS: BMPR2 loss reverses the endothelial response to BMP9, causing enhanced proliferation. This finding has potential implications for the proposed translation of BMP9 as a treatment for pulmonary arterial hypertension and suggests the need for focused patient selection in clinical trials. GRAPHIC ABSTRACT: A graphic abstract is available for this article.
format Online
Article
Text
id pubmed-7571847
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75718472020-10-29 Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling Theilmann, Anne L. Hawke, Lindsey G. Hilton, L. Rhiannon Whitford, Mara K.M. Cole, Devon V. Mackeil, Jodi L. Dunham-Snary, Kimberly J. Mewburn, Jeffrey James, Paula D. Maurice, Donald H. Archer, Stephen L. Ormiston, Mark L. Arterioscler Thromb Vasc Biol Basic Sciences Pulmonary arterial hypertension is a disease of proliferative vascular occlusion that is strongly linked to mutations in BMPR2—the gene encoding the BMPR-II (BMP [bone morphogenetic protein] type II receptor). The endothelial-selective BMPR-II ligand, BMP9, reverses disease in animal models of pulmonary arterial hypertension and suppresses the proliferation of healthy endothelial cells. However, the impact of BMPR2 loss on the antiproliferative actions of BMP9 has yet to be assessed. APPROACH AND RESULTS: BMP9 suppressed proliferation in blood outgrowth endothelial cells from healthy control subjects but increased proliferation in blood outgrowth endothelial cells from pulmonary arterial hypertension patients with BMPR2 mutations. This shift from growth suppression to enhanced proliferation was recapitulated in control human pulmonary artery endothelial cells following siRNA-mediated BMPR2 silencing, as well as in mouse pulmonary endothelial cells isolated from endothelial-conditional Bmpr2 knockout mice (Bmpr2(EC)(−/−)). BMP9-induced proliferation was not attributable to altered metabolic activity or elevated TGFβ (transforming growth factor beta) signaling but was linked to the prolonged induction of the canonical BMP target ID1 in the context of BMPR2 loss. In vivo, daily BMP9 administration to neonatal mice impaired both retinal and lung vascular patterning in control mice (Bmpr2(EC+/+)) but had no measurable effect on mice bearing a heterozygous endothelial Bmpr2 deletion (Bmpr2(EC+/−)) and caused excessive angiogenesis in both vascular beds for Bmpr2(EC)(−/−) mice. CONCLUSIONS: BMPR2 loss reverses the endothelial response to BMP9, causing enhanced proliferation. This finding has potential implications for the proposed translation of BMP9 as a treatment for pulmonary arterial hypertension and suggests the need for focused patient selection in clinical trials. GRAPHIC ABSTRACT: A graphic abstract is available for this article. Lippincott Williams & Wilkins 2020-10-01 2020-11 /pmc/articles/PMC7571847/ /pubmed/32998516 http://dx.doi.org/10.1161/ATVBAHA.119.313357 Text en © 2020 The Authors. Arteriosclerosis, Thrombosis, and Vascular Biology is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
spellingShingle Basic Sciences
Theilmann, Anne L.
Hawke, Lindsey G.
Hilton, L. Rhiannon
Whitford, Mara K.M.
Cole, Devon V.
Mackeil, Jodi L.
Dunham-Snary, Kimberly J.
Mewburn, Jeffrey
James, Paula D.
Maurice, Donald H.
Archer, Stephen L.
Ormiston, Mark L.
Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling
title Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling
title_full Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling
title_fullStr Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling
title_full_unstemmed Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling
title_short Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling
title_sort endothelial bmpr2 loss drives a proliferative response to bmp (bone morphogenetic protein) 9 via prolonged canonical signaling
topic Basic Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571847/
https://www.ncbi.nlm.nih.gov/pubmed/32998516
http://dx.doi.org/10.1161/ATVBAHA.119.313357
work_keys_str_mv AT theilmannannel endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT hawkelindseyg endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT hiltonlrhiannon endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT whitfordmarakm endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT coledevonv endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT mackeiljodil endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT dunhamsnarykimberlyj endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT mewburnjeffrey endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT jamespaulad endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT mauricedonaldh endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT archerstephenl endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling
AT ormistonmarkl endothelialbmpr2lossdrivesaproliferativeresponsetobmpbonemorphogeneticprotein9viaprolongedcanonicalsignaling